Indian Guaifenesin Exporters: Complete Supplier Ranking with Market Share — 151 Manufacturers (2026) — TransData Nexus

Q: Who is the largest guaifenesin supplier from India?

GRANULES INDIA LIMITED is the largest guaifenesin exporter from India with a 35.4% market share and export value of $9.4M.

Q: How many guaifenesin suppliers are there in India?

There are 151 active guaifenesin exporters in India, collectively shipping $26.7M worth of guaifenesin across 1,050 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top guaifenesin suppliers from India?

The top 5 guaifenesin suppliers from India — GRANULES INDIA LIMITED, ELYSIUM PHARMACEUTICALS LTD, SUN PHARMACEUTICAL INDUSTRIES LIMITED, BRAWN LABORATORIES LIMITED, AGIO PHARMACEUTICALS LIMITED — together control 62.8% of total guaifenesin export value from India.

Suresh Sormare

Guaifenesin

India Pharmaceutical Trade Intelligence

$26.7M151 Suppliers77 CountriesHS 30049099

ExportsIndia → UNITED STATES69.6%India → IRAQ3.4%

#1 Supplier: GRANULES INDIA #1 Buyer: GRANULES CONSUMER

Guaifenesin Suppliers from India (2026) — 151 Exporters, $26.7M Market | TransData Nexus | TransData Nexus

Who Exports Guaifenesin from India — 151 Suppliers Behind a $26.7M Market

India's guaifenesin export market is supplied by 151 active exporters who collectively shipped $26.7M across 1,050 shipments. GRANULES INDIA LIMITED leads with a 35.4% market share, followed by ELYSIUM PHARMACEUTICALS LTD and SUN PHARMACEUTICAL INDUSTRIES LIMITED. The top 5 suppliers together control 62.8% of total export value, reflecting a concentrated market structure.

Source: Indian Customs (DGFT)·Published March 2026

India's Top Guaifenesin Suppliers & Exporters — 151 manufacturers, $26.7M export market, top destinations and formulations — Guaifenesin supplier data — 151 exporters · $26.7M market · 1,050 shipmentsTransData Nexus · Indian Customs Data

Top Guaifenesin Exporters from India — Ranked by Export Value

GRANULES INDIA LIMITED is the leading guaifenesin exporter from India, holding a 35.4% share of the $26.7M market across 1,050 shipments from 151 exporters. The top 5 suppliers — GRANULES INDIA LIMITED, ELYSIUM PHARMACEUTICALS LTD, SUN PHARMACEUTICAL INDUSTRIES LIMITED, BRAWN LABORATORIES LIMITED, AGIO PHARMACEUTICALS LIMITED — collectively control 62.8% of total export value, indicating a moderately concentrated market. Individual shares are: GRANULES INDIA LIMITED (35.4%), ELYSIUM PHARMACEUTICALS LTD (18.1%), SUN PHARMACEUTICAL INDUSTRIES LIMITED (3.4%), BRAWN LABORATORIES LIMITED (3.0%), AGIO PHARMACEUTICALS LIMITED (2.9%).

Top Guaifenesin Exporters from India

Ranked by export value · 151 active suppliers · Indian Customs (DGFT) data

Mar 2026

Top Guaifenesin Exporters from India — Ranked by Export Value. 151 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Guaifenesin exporters

Certification and compliance status for top Guaifenesin suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
Granules India Limited	Warning Letter (February	Unknown	Unknown	Not verified	FDA issued a warning letter citing significant CGMP violations at the Gagillapur
Glenmark Pharmaceuticals Limited	Warning Letter (July 2025	Unknown	Unknown	Not verified	FDA issued a warning letter for CGMP violations at the Pithampur facility.
Emcure Pharmaceuticals Limited	Warning Letter (August 20	Unknown	Unknown	Not verified	FDA issued a warning letter for CGMP violations at the Hinjawadi facility.
Cadila Pharmaceuticals Limited	Warning Letter (2015)	Unknown	Unknown	Not verified	FDA issued a warning letter for CGMP violations.
Dr. Reddy's Laboratories Ltd	Warning Letter (2015)	Unknown	Unknown	Not verified	FDA issued a warning letter for CGMP violations.
Sun Pharmaceutical Industries Limited	Warning Letter (2016)	Unknown	Unknown	Not verified	FDA issued a warning letter for CGMP violations.
Ipca Laboratories Ltd	Warning Letter (2016)	Unknown	Unknown	Not verified	FDA issued a warning letter for CGMP violations.
Wockhardt Limited	Warning Letter (2013)	Unknown	Unknown	Not verified	FDA issued a warning letter for CGMP violations.

TransData Nexus reviewed the regulatory standing of 8 leading Guaifenesin exporters from India. 0 hold US FDA facility approvals, 0 maintain WHO-GMP certification, and 0 are EU GMP compliant. 8 suppliers have received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Guaifenesin sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Bulk Drug Capital of India," contributes to more than 40% of the country's bulk drug production. The city hosts numerous manufacturers specializing in Active Pharmaceutical Ingredients (APIs) and bulk drugs, including Guaifenesin. Companies such as SVK Laboratories Private Limited and Vasudha Pharma Chem Ltd. are prominent players in this sector. SVK Laboratories, established in 2007, focuses on producing high-quality APIs and intermediates, adhering to Good Manufacturing Practices (GMP) and international standards. Similarly, Vasudha Pharma Chem Ltd., located in Jeedimetla, Hyderabad, specializes in bulk drug manufacturing and has a significant presence in the global market.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its pharmaceutical formulations. Vadodara, in particular, hosts companies like Mercury Laboratories Limited, which has been a leading pharmaceutical manufacturer for over five decades, offering a diverse product portfolio across multiple therapeutic segments. Additionally, Alembic Pharmaceuticals, headquartered in Vadodara, is a significant player in the formulations sector, manufacturing and marketing a wide range of pharmaceutical products, including APIs and formulations. These companies' expertise in formulations positions them as potential partners for Guaifenesin production and export.

Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Guaifenesin exporters from India

November 2025

M&A

GRANULES INDIA LIMITED — Granules India acquires Senn Chemicals to enhance peptide therapeutics and CDMO services

Granules India Limited announced the completion of its acquisition of Senn Chemicals, a Swiss-based company specializing in peptide synthesis and contract development and manufacturing organization (CDMO) services. This strategic move aims to strengthen Granules India's capabilities in peptide therapeutics and expand its CDMO offerings.

Impact: The acquisition is expected to diversify Granules India's product portfolio, potentially influencing its Guaifenesin export focus.

June 2023

M&A

SUN PHARMACEUTICAL INDUSTRIES LIMITED — Sun Pharma acquires 60% stake in Vivaldis Health and Foods

Sun Pharmaceutical Industries Limited completed the acquisition of a 60% shareholding in Vivaldis Health and Foods Private Limited, a company specializing in animal healthcare products. This acquisition is part of Sun Pharma's strategy to diversify its product offerings and enter the animal healthcare segment.

Impact: The focus on animal healthcare may lead to a reallocation of resources, potentially affecting Guaifenesin export volumes.

Common Questions — Guaifenesin Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which guaifenesin supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, GRANULES INDIA LIMITED leads with 181 recorded shipments worth $9.4M. ELYSIUM PHARMACEUTICALS LTD (77 shipments) and SUN PHARMACEUTICAL INDUSTRIES LIMITED (31 shipments) are also established high-volume exporters.

Q How many guaifenesin manufacturers are there in India?

India has 151 active guaifenesin exporters with a combined export market of $26.7M across 1,050 shipments to 77 countries. The top 5 suppliers hold 62.8% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for guaifenesin from India?

Average FOB unit price: $15.77 per unit, ranging from $0.01 to $398.12. Average shipment value: $25.4K.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Guaifenesin

Guaifenesin

Who Exports Guaifenesin from India — 151 Suppliers Behind a $26.7M Market

Top Guaifenesin Exporters from India — Ranked by Export Value

Top Guaifenesin Exporters from India

Related Analysis

Need Details?

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

GRANULES INDIA LIMITED — Granules India acquires Senn Chemicals to enhance peptide therapeutics and CDMO services

SUN PHARMACEUTICAL INDUSTRIES LIMITED — Sun Pharma acquires 60% stake in Vivaldis Health and Foods

Common Questions — Guaifenesin Suppliers from India

Q Which guaifenesin supplier from India is the most reliable for bulk orders?

Q How many guaifenesin manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for guaifenesin from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

SUN PHARMACEUTICAL INDUSTRIES LIMITED — Sun Pharma merges with Taro Pharmaceuticals, acquiring remaining stake

Analysis Methodology